FindTrial
Sign In

A study of non-target disease progression/reversal factors in patients with coronary heart disease after PCI

An open bidirectional cohort study of non-target disease progression/reversal factors in patients with coronary heart disease after PCI

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200058529
Enrollment
Unknown
Registered
2022-04-10
Start date
2022-04-11
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary heart disease

Interventions

Experimental group:Percutaneous coronary intervention (PCI)

Sponsors

The Second Affiliated Hospital of Dalian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Clear diagnosis of coronary heart disease; 2. PCI guided by IVUS/OCT; 3. Aged 18-80 years; 4. Patients or their family members sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients during pregnancy and lactation or who plan to become pregnant within 2 years; 2. Allergy to contrast agent; 3. The researcher judged poor compliance and could not complete the interview.

Design outcomes

Primary

MeasureTime frame
plaque volume;composition of plaque;patch characteristics;—

Countries

China

Contacts

Public ContactQu Peng
qupeng777@aliyun.com+86 13304261697

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 5, 2026